Li Kang, Li Bin, Zhang Dihua, Du Tailai, Zhou Huimin, Dai Gang, Yan Youchen, Gao Nailin, Zhuang Xiaodong, Liao Xinxue, Liu Chen, Dong Yugang, Chen Demeng, Qu Liang-Hu, Ou Jingsong, Yang Jian-Hua, Huang Zhan-Peng
1Department of Cardiology, Center for Translational Medicine, Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan Er Road, Guangzhou 510080, China.
NHC Key Laboratory of Assisted Circulation (Sun Yat-sen University), 58 Zhongshan Er Road, Guangzhou 510080, China.
Cardiovasc Res. 2023 Jul 6;119(8):1763-1779. doi: 10.1093/cvr/cvad044.
The plasticity of vascular smooth muscle cells (VSMCs) enables them to alter phenotypes under various physiological and pathological stimuli. The alteration of VSMC phenotype is a key step in vascular diseases, including atherosclerosis. Although the transcriptome shift during VSMC phenotype alteration has been intensively investigated, uncovering multiple key regulatory signalling pathways, the translatome dynamics in this cellular process, remain largely unknown. Here, we explored the genome-wide regulation at the translational level of human VSMCs during phenotype alteration.
We generated nucleotide-resolution translatome and transcriptome data from human VSMCs undergoing phenotype alteration. Deep sequencing of ribosome-protected fragments (Ribo-seq) revealed alterations in protein synthesis independent of changes in messenger ribonucleicacid levels. Increased translational efficiency of many translational machinery components, including ribosomal proteins, eukaryotic translation elongation factors and initiation factors were observed during the phenotype alteration of VSMCs. In addition, hundreds of candidates for short open reading frame-encoded polypeptides (SEPs), a class of peptides containing 200 amino acids or less, were identified in a combined analysis of translatome and transcriptome data with a high positive rate in validating their coding capability. Three evolutionarily conserved SEPs were further detected endogenously by customized antibodies and suggested to participate in the pathogenesis of atherosclerosis by analysing the transcriptome and single cell RNA-seq data from patient atherosclerotic artery samples. Gain- and loss-of-function studies in human VSMCs and genetically engineered mice showed that these SEPs modulate the alteration of VSMC phenotype through different signalling pathways, including the mitogen-activated protein kinase pathway and p53 pathway.
Our study indicates that an increase in the capacity of translation, which is attributable to an increased quantity of translational machinery components, mainly controls alterations of VSMC phenotype at the level of translational regulation. In addition, SEPs could function as important regulators in the phenotype alteration of human VSMCs.
血管平滑肌细胞(VSMC)的可塑性使其能够在各种生理和病理刺激下改变表型。VSMC表型的改变是包括动脉粥样硬化在内的血管疾病的关键步骤。尽管VSMC表型改变过程中的转录组变化已得到深入研究,揭示了多个关键调控信号通路,但该细胞过程中的翻译组动态变化仍 largely未知。在此,我们探索了人类VSMC表型改变过程中翻译水平的全基因组调控。
我们从经历表型改变的人类VSMC中生成了核苷酸分辨率的翻译组和转录组数据。核糖体保护片段(Ribo-seq)的深度测序揭示了蛋白质合成的改变,而这种改变与信使核糖核酸水平的变化无关。在VSMC表型改变过程中,观察到许多翻译机器组件(包括核糖体蛋白、真核翻译延伸因子和起始因子)的翻译效率增加。此外,在翻译组和转录组数据的联合分析中,鉴定出数百个短开放阅读框编码多肽(SEP)的候选物,这是一类包含200个氨基酸或更少的肽,在验证其编码能力方面具有很高的阳性率。通过定制抗体进一步内源性检测到三种进化保守的SEP,并通过分析患者动脉粥样硬化动脉样本的转录组和单细胞RNA-seq数据,提示它们参与动脉粥样硬化的发病机制。在人类VSMC和基因工程小鼠中的功能获得和丧失研究表明,这些SEP通过不同的信号通路(包括丝裂原活化蛋白激酶通路和p53通路)调节VSMC表型的改变。
我们的研究表明,翻译能力的增加(这归因于翻译机器组件数量的增加)主要在翻译调控水平上控制VSMC表型的改变。此外,SEP可能作为人类VSMC表型改变的重要调节因子发挥作用。